marketcap
Facebook
Twitter
Telegram
Fehler meldenGeschäftsbericht 2024
hinzugefügt 25.02.2025
Cogent Biosciences Kennzahlen 2011-2025 | COGT
Kennzahlen Jährlich Cogent Biosciences
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-2.9 | -3.1 | -5.4 | -3.2 | -0.2 | -0.7 | -2.9 | -0.9 | -1.2 | - | - | - | - | - |
P/S |
- | - | - | - | 2.2 | 1.0 | 10.1 | 2.7 | 3.5 | - | - | - | - | - |
EPS |
-1.9 | -1.9 | -1.7 | -1.9 | -16.2 | -4.2 | -1.4 | -2.5 | - | - | - | - | - | - |
EV (Enterprise Value) |
708 M | 600 M | 668 M | 26.6 M | -208 M | 3.1 M | 68.6 M | 14 M | 45.7 M | - | - | - | - | - |
EBITDA per Share |
-2.63 | -2.58 | -2.5 | -1.95 | -40.7 | -4.05 | -5.57 | -4.27 | -3.12 | - | - | - | - | - |
EV/EBITDA |
0.1 | 2.7 | 0.5 | -1.2 | 0.2 | 1.0 | - | - | - | - | - | |||
PEG |
-0.02 | -0.02 | -0.03 | -0.02 | 0.0 | -0.03 | 0.1 | 0.16 | 0.23 | - | - | - | - | - |
P/B |
2.9 | 2.3 | 3.0 | 1.1 | 0.1 | 0.7 | 1.6 | 0.8 | 0.4 | - | - | - | - | - |
P/CF |
-3.5 | -3.9 | -6.4 | -3.9 | -0.5 | -0.6 | -3.0 | -0.9 | -1.0 | - | - | - | - | - |
ROE % |
-99.83 | -74.63 | -54.84 | -33.74 | -31.88 | -100.22 | -57.33 | -90.06 | -34.60 | - | - | - | - | - |
ROA % |
-78.03 | -61.39 | -46.62 | -31.14 | -29.81 | -64.41 | -40.19 | -51.90 | -23.99 | - | - | - | - | - |
ROCE % |
-107.67 | -80.73 | -57.81 | -35.27 | -34.56 | -88.95 | -59.04 | -67.22 | -27.13 | - | - | - | - | - |
Current Ratio |
4.6 | 5.6 | 6.7 | 13.0 | 18.7 | 3.1 | 3.2 | 3.8 | 8.0 | - | - | - | - | - |
DSO |
- | - | - | - | - | 32.4 | 62.5 | 36.2 | 53.3 | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebszyklus |
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
Finanzkreislauf |
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Kennzahlen Vierteljährlich Cogent Biosciences
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.64 | -0.59 | -0.62 | - | -0.64 | -0.59 | -0.55 | - | -0.5 | -0.71 | -0.68 | - | -0.48 | -0.43 | -0.34 | - | -5.07 | -0.95 | -0.81 | 0.07 | -0.39 | -0.34 | -0.39 | -0.29 | -0.34 | -0.31 | -0.66 | -0.66 | -0.69 | -0.58 | -0.58 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -0.65 | - | - | - | -0.6 | - | -0.52 | -0.72 | -0.7 | - | -0.5 | -0.45 | -0.37 | - | -5.74 | -0.88 | -0.78 | - | - | - | - | - | - | - | - | -0.67 | -0.62 | -0.54 | -0.57 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-70.34 | -66.18 | -63.03 | -48.19 | -60.29 | -54.10 | -52.38 | -39.34 | -49.01 | -46.59 | -43.43 | -22.62 | -43.92 | -55.55 | -50.92 | -27.05 | -19.81 | -36.05 | -66.01 | -100.22 | -121.74 | -141.48 | -165.65 | -186.12 | -158.13 | -86.53 | -17.25 | -12.17 | -25.87 | -40.20 | -52.20 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-59.94 | -57.13 | -54.65 | -41.48 | -52.05 | -47.04 | -45.35 | -34.92 | -43.79 | -42.07 | -39.77 | -21.04 | -40.96 | -52.02 | -47.72 | -25.30 | -20.65 | -24.85 | -43.18 | -64.41 | -79.07 | -95.10 | -113.97 | -130.47 | -134.07 | -108.17 | -79.96 | 12.11 | 25.73 | 39.98 | 51.92 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-75.66 | -71.37 | -67.63 | -52.52 | -65.22 | -58.25 | -55.97 | -40.65 | -50.70 | -48.05 | -44.95 | -23.82 | -48.19 | -62.52 | -57.55 | -30.15 | -23.09 | -36.61 | -66.65 | -101.31 | -123.31 | -102.97 | -85.46 | -59.78 | -30.74 | 1.50 | 29.52 | 53.54 | 39.45 | 24.78 | 12.42 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
5.5 | 7.6 | 8.8 | 5.6 | 6.8 | 8.9 | 6.6 | 6.7 | 8.0 | 7.8 | 10.9 | 13.0 | 11.9 | 14.5 | 21.9 | 15.4 | 15.4 | 15.4 | 15.4 | 2.8 | 2.8 | 2.8 | 2.8 | 3.3 | 3.3 | 3.3 | 3.3 | 2.4 | 2.4 | 2.4 | 2.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 13.0 | 11.9 | 178.9 | 58.2 | 54.8 | 40.0 | 74.5 | 91.4 | 51.3 | 35.7 | 32.5 | 36.4 | 20.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebszyklus |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 13.0 | 11.9 | 178.9 | 58.2 | 54.8 | 40.0 | 74.5 | 91.4 | 51.3 | 35.7 | 32.5 | 36.4 | 20.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Finanzkreislauf |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 13.0 | 11.9 | 178.9 | 58.2 | 54.8 | 40.0 | 74.5 | 91.4 | 51.3 | 35.7 | 32.5 | 36.4 | 20.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung